The devices have surged in popularity among people without diabetes, but a study suggests reality may not match the hype.View ...

Key market opportunities include increasing adoption of OTC continuous glucose monitoring (CGM) devices driven by lifestyle ...

The FDA has approved San Diego, California-based Dexcom for a Bluetooth-enabled continuous glucose monitor (CGM), called the G5 Mobile CGM system. Correction: A previous version of this article ...

Biolinq announced today that it received FDA de novo clearance for its lead product, the Biolinq Shine wearable biosensor.

Manage diabetes and not CGM interruptions with the new Eversense 365 CGM system – the only One Year CGM that is designed to help minimize device frustrations Ascensia launches the world’s first One ...

July 1, 2011 (San Diego, California) — A pilot study presented here at the American Diabetes Association (ADA) 71st Scientific Sessions suggests that the use of continuous glucose monitoring (CGM) ...

Continuous glucose monitoring can be successfully initiated during hospitalization with training for hospital staff, robust ...

The Food and Drug Administration has granted de novo classification to a continuous glucose monitor made by Biolinq for ...

To hear some of them tell it, the companies selling continuous glucose monitors have stumbled upon a heretofore unknown quirk of human biology. Seemingly healthy people, many of these companies argue, ...

Please provide your email address to receive an email when new articles are posted on . McKee and colleagues conducted a retrospective survey of adults attending the Washington ...

Pharmacists face pressure to prioritize speed over patient education, impacting diabetes care quality and adherence to CGM devices. A CCS report found that pharmacists lack time for diabetes education ...